Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.7450
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.7000/ 4
- Ask / Lots1.7500/ 5
- Open / Previous Close0.0000 / 1.7450
- Day Range---
- 52 Week Range
- Volume40
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 423 | 1.74 |
| 09:36 ET | 635 | 1.7499 |
| 09:39 ET | 3200 | 1.75 |
| 09:50 ET | 1000 | 1.74 |
| 09:54 ET | 100 | 1.7483 |
| 09:56 ET | 100 | 1.748 |
| 09:59 ET | 12195 | 1.725 |
| 10:01 ET | 6308 | 1.72 |
| 10:12 ET | 100 | 1.7361 |
| 10:14 ET | 100 | 1.7372 |
| 10:17 ET | 200 | 1.735 |
| 10:24 ET | 1610 | 1.7101 |
| 10:28 ET | 200 | 1.722 |
| 10:37 ET | 500 | 1.73 |
| 10:44 ET | 100 | 1.748 |
| 10:53 ET | 6200 | 1.7401 |
| 11:04 ET | 1000 | 1.73 |
| 11:06 ET | 1000 | 1.73 |
| 11:08 ET | 100 | 1.74 |
| 11:20 ET | 7233 | 1.7399 |
| 11:22 ET | 25448 | 1.7498 |
| 11:24 ET | 31637 | 1.75 |
| 11:26 ET | 300 | 1.75 |
| 11:29 ET | 100 | 1.75 |
| 11:31 ET | 1900 | 1.74 |
| 11:51 ET | 100 | 1.75 |
| 12:00 ET | 100 | 1.75 |
| 12:09 ET | 200 | 1.75 |
| 12:20 ET | 100 | 1.75 |
| 12:27 ET | 100 | 1.75 |
| 12:38 ET | 100 | 1.75 |
| 12:48 ET | 100 | 1.75 |
| 12:56 ET | 100 | 1.75 |
| 01:01 ET | 100 | 1.75 |
| 01:06 ET | 100 | 1.75 |
| 01:15 ET | 100 | 1.75 |
| 01:17 ET | 1750 | 1.7394 |
| 01:19 ET | 200 | 1.735 |
| 01:26 ET | 100 | 1.74 |
| 01:35 ET | 100 | 1.74 |
| 01:46 ET | 100 | 1.74 |
| 01:50 ET | 400 | 1.74 |
| 01:55 ET | 100 | 1.74 |
| 02:04 ET | 100 | 1.74 |
| 02:06 ET | 100 | 1.74 |
| 02:09 ET | 4746 | 1.725 |
| 02:27 ET | 4450 | 1.72 |
| 02:40 ET | 1200 | 1.72 |
| 02:42 ET | 200 | 1.725 |
| 02:44 ET | 7950 | 1.72 |
| 02:45 ET | 4500 | 1.71 |
| 03:05 ET | 200 | 1.73 |
| 03:09 ET | 1000 | 1.7177 |
| 03:12 ET | 100 | 1.72 |
| 03:14 ET | 100 | 1.73 |
| 03:20 ET | 100 | 1.73 |
| 03:25 ET | 100 | 1.73 |
| 03:27 ET | 200 | 1.71 |
| 03:30 ET | 8227 | 1.72 |
| 03:34 ET | 100 | 1.74 |
| 03:38 ET | 600 | 1.74 |
| 03:41 ET | 100 | 1.73 |
| 03:43 ET | 100 | 1.74 |
| 03:45 ET | 190 | 1.7395 |
| 03:48 ET | 100 | 1.74 |
| 03:52 ET | 100 | 1.74 |
| 03:54 ET | 100 | 1.74 |
| 03:56 ET | 100 | 1.74 |
| 03:57 ET | 2666 | 1.735 |
| 03:59 ET | 11711 | 1.745 |
May 16, 2024
DJ Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co., from 8:02AM ET on Thursday May 16, 2024 by Dow Jones
8:02AM ET on Thursday May 16, 2024 by Dow Jones
May 13, 2024
*DJ Milestone Pharmaceuticals 1Q Loss $10.4M >MIST, from 7:15AM ET on Monday May 13, 2024 by Dow Jones
7:15AM ET on Monday May 13, 2024 by Dow JonesMilestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update, from 7:15AM ET on Monday May 13, 2024 by Dow Jones
7:15AM ET on Monday May 13, 2024 by Dow Jones
May 2, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 92.9M | -1.4x | --- |
Barinthus Biotherapeutics PLC | 93.4M | -1.3x | --- |
Yubo International Biotech Ltd | 92.3M | -77.2x | --- |
Nanopharmaceutics Inc | 93.9M | -152.4x | --- |
Oramed Pharmaceuticals Inc | 96.3M | 9.5x | --- |
Connect Biopharma Holdings Ltd | 92.0M | -1.5x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $92.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.76 |
EPS | $-1.25 |
Book Value | $0.50 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
